Sander de Vos

Sander de Vos is a seasoned professional in the life science and health sector, currently serving as Chief Business Officer at PathoFinder B.V. and PathoNostics, and Chief Business Officer at Rapidemic. Additionally, Sander is the founder and owner of Shift Life Science & Health, specializing in consultancy for life science companies. Previous roles include Chief Business Officer at VIVOLTA, Director of Sales at MIMETAS, Sales Manager at Isogen Life Science, and various positions at Westburg BV, including Sales Manager and Product Specialist. Sander began a scientific career at Universiteit Utrecht, focusing on parasitology and tropical veterinary medicine, and holds a Bachelor’s degree in Molecular Biology from HU University of Applied Sciences Utrecht. Publications include research on the Bm86 antigen from Boophilus microplus and its implications for vaccination against other tick species.